These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38631033)

  • 21. Racial and Ethnic Digital Divides in Posting COVID-19 Content on Social Media Among US Adults: Secondary Survey Analysis.
    Campos-Castillo C; Laestadius LI
    J Med Internet Res; 2020 Jul; 22(7):e20472. PubMed ID: 32568726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between COVID-19 Exposure and Self-reported Compliance With Public Health Guidelines Among Essential Employees at an Institution of Higher Education in the US.
    Nelson TL; Fosdick BK; Biela LM; Schoenberg H; Mast S; McGinnis E; Young MC; Lynn L; Fahrner S; Nolt L; Dihle T; Quicke K; Gallichotte EN; Fitzmeyer E; Ebel GD; Pabilonia K; Ehrhart N; VandeWoude S
    JAMA Netw Open; 2021 Jul; 4(7):e2116543. PubMed ID: 34287634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine, Cost-Effective SARS-CoV-2 Surveillance Testing Using Pooled Saliva Limits Viral Spread on a Residential College Campus.
    Vander Schaaf NA; Fund AJ; Munnich BV; Zastrow AL; Fund EE; Senti TL; Lynn AF; Kane JJ; Love JL; Long GJ; Troendle NJ; Sharda DR
    Microbiol Spectr; 2021 Oct; 9(2):e0108921. PubMed ID: 34643445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a novel university-based testing platform to increase access to SARS-CoV-2 testing during the COVID-19 pandemic in a cohort study.
    Bennett JC; O'Hanlon J; Acker Z; Han PD; McDonald D; Wright T; Luiten KG; Regelbrugge L; McCaffrey KM; Pfau B; Wolf CR; Gottlieb GS; Hughes JP; Carone M; Starita LM; Chu HY; Weil AA
    BMJ Open; 2024 Jun; 14(6):e081837. PubMed ID: 38834321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
    Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
    Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of SARS-CoV-2 Testing Preferences in a National Cohort in the United States: Latent Class Analysis of a Discrete Choice Experiment.
    Zimba R; Romo ML; Kulkarni SG; Berry A; You W; Mirzayi C; Westmoreland DA; Parcesepe AM; Waldron L; Rane MS; Kochhar S; Robertson MM; Maroko AR; Grov C; Nash D
    JMIR Public Health Surveill; 2021 Dec; 7(12):e32846. PubMed ID: 34793320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus.
    Ehrenberg AJ; Moehle EA; Brook CE; Doudna Cate AH; Witkowsky LB; Sachdeva R; Hirsh A; Barry K; Hamilton JR; Lin-Shiao E; McDevitt S; Valentin-Alvarado L; Letourneau KN; Hunter L; Keller A; Pestal K; Frankino PA; Murley A; Nandakumar D; Stahl EC; Tsuchida CA; Gildea HK; Murdock AG; Hochstrasser ML; O'Brien E; Ciling A; Tsitsiklis A; Worden K; Dugast-Darzacq C; Hays SG; Barber CC; McGarrigle R; Lam EK; Ensminger DC; Bardet L; Sherry C; Harte A; Nicolette G; Giannikopoulos P; Hockemeyer D; Petersen M; Urnov FD; Ringeisen BR; Boots M; Doudna JA;
    PLoS One; 2021; 16(5):e0251296. PubMed ID: 34038425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
    Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.
    Laeyendecker O; Hsieh YH; Rothman RE; Dashler G; Kickler T; Fernandez RE; Clarke W; Patel EU; Tobian AAR; Kelen GD; Quinn TC;
    Am J Emerg Med; 2021 Oct; 48():261-268. PubMed ID: 34015609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Comprehensive COVID-19 Testing Program Outcomes in a US Dental Clinical Care Academic Setting.
    Choi SE; Sima C; Colom LP; Nguyen GT; Giannobile WV
    JAMA Netw Open; 2022 Dec; 5(12):e2246530. PubMed ID: 36512355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of high-frequency in-pipe SARS-CoV-2 wastewater-based surveillance to concurrent COVID-19 random clinical testing on a public U.S. university campus.
    Wright J; Driver EM; Bowes DA; Johnston B; Halden RU
    Sci Total Environ; 2022 May; 820():152877. PubMed ID: 34998780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey.
    Monnig MA; Treloar Padovano H; Sokolovsky AW; DeCost G; Aston ER; Haass-Koffler CL; Szapary C; Moyo P; Avila JC; Tidey JW; Monti PM; Ahluwalia JS
    JMIR Public Health Surveill; 2021 Nov; 7(11):e29319. PubMed ID: 34591780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.